Cargando…

Exploring sub-optimal response to tumour necrosis factor inhibitors in axial spondyloarthritis

OBJECTIVES: The aim was to define sub-optimal response to TNF inhibitors (TNFi), compare long-term drug survival rates and identify predictors of sub-optimal response in axial spondyloarthritis (axSpA) patients in a UK cohort. METHODS: All axSpA patients attending two centres who commenced TNFi betw...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yahya, Fariz, Gaffney, Karl, Sengupta, Raj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Concise Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649897/ https://www.ncbi.nlm.nih.gov/pubmed/31432000 http://dx.doi.org/10.1093/rap/rkz012

Ejemplares similares

Comment on: Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis—findings from a United Kingdom cohort: reply
por: Yahya, Fariz, et al.
Publicado: (2018)

Influence of co-morbid fibromyalgia on disease activity measures and response to tumour necrosis factor inhibitors in axial spondyloarthritis: results from a UK national register
por: Macfarlane, Gary J, et al.
Publicado: (2018)

Services provided for axial spondyloarthritis patients by rheumatologists in India: a survey
por: Pathak, Himanshu, et al.
Publicado: (2021)

Comment on: Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis—findings from a United Kingdom cohort
por: Al Arashi, Wala, et al.
Publicado: (2018)

Response to lower dose TNF inhibitors in axial spondyloarthritis; a real-world multicentre observational study
por: Van Rossen, Liz, et al.
Publicado: (2020)

Smoking status and cause-specific discontinuation of tumour necrosis factor inhibitors in axial spondyloarthritis
por: Zhao, Sizheng Steven, et al.
Publicado: (2019)

Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis
por: Micheroli, Raphael, et al.
Publicado: (2017)

Defining the target: clinical aims in axial spondyloarthritis
por: Marzo-Ortega, Helena, et al.
Publicado: (2018)

Use of Complementary and Alternative Medicine in Axial Spondyloarthritis: A Qualitative Exploration of Self-Management
por: Jordan, Abbie, et al.
Publicado: (2019)

A cluster analysis of patients with axial spondyloarthritis using tumour necrosis factor alpha inhibitors based on clinical characteristics
por: Lee, Seulkee, et al.
Publicado: (2021)

Tumour necrosis factor inhibitor dose adaptation in psoriatic arthritis and axial spondyloarthritis (TAPAS): a retrospective cohort study
por: Michielsens, Celia A J, et al.
Publicado: (2021)

Awareness of axial spondyloarthritis among chiropractors and osteopaths: findings from a UK Web-based survey
por: Yong, Cee Y, et al.
Publicado: (2019)

Diagnostic delay is common for patients with axial spondyloarthritis: results from the National Early Inflammatory Arthritis Audit
por: Russell, Mark D, et al.
Publicado: (2021)

Axial spondyloarthritis 10 years on: still looking for the lost tribe
por: Barnett, Rosemarie, et al.
Publicado: (2020)

Corrigendum to: Diagnostic delay is common for patients with axial spondyloarthritis: results from the National Early Inflammatory Arthritis Audit
por: Russell, Mark D, et al.
Publicado: (2021)

Treatment with tumour necrosis factor inhibitors is associated with a time-shifted retardation of radiographic spinal progression in patients with axial spondyloarthritis
por: Torgutalp, Murat, et al.
Publicado: (2022)

Effect of tumor necrosis factor inhibitors on risk of cardiovascular disease in patients with axial spondyloarthritis
por: Kwon, Oh Chan, et al.
Publicado: (2022)

Erratum to: Axial spondyloarthritis 10 years on: still looking for the lost tribe
por: Barnett, Rosemarie, et al.
Publicado: (2020)

Real-world evidence for secukinumab in UK patients with psoriatic arthritis or radiographic axial spondyloarthritis: interim 2-year analysis from SERENA
por: Gaffney, Karl, et al.
Publicado: (2023)

JAK Inhibitors for the Treatment of Axial Spondyloarthritis
por: Klavdianou, Kalliopi, et al.
Publicado: (2023)

The prevalence of axial spondyloarthritis in the UK: a cross-sectional cohort study
por: Hamilton, Louise, et al.
Publicado: (2015)

Site-specific resolution of enthesitis in patients with axial spondyloarthritis treated with tumor necrosis factor inhibitors
por: Nissen, Michael J., et al.
Publicado: (2021)

First Spanish study on the effectiveness of ultrasound-guided sacroiliac joint injection in patients with spondyloarthritis
por: Ramírez Huaranga, Marco A, et al.
Publicado: (2022)

Treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope
por: Zhao, Sizheng Steven, et al.
Publicado: (2023)

Identifying parameters associated with delayed diagnosis in axial spondyloarthritis: data from the European map of axial spondyloarthritis
por: Garrido-Cumbrera, Marco, et al.
Publicado: (2021)

Understanding flare in axial spondyloarthritis: novel insights from daily self-reported flare experience
por: Barnett, Rosemarie, et al.
Publicado: (2021)

Comorbidity and response to TNF inhibitors in axial spondyloarthritis: longitudinal analysis of the BSRBR-AS
por: Zhao, Sizheng Steven, et al.
Publicado: (2020)

Peripheral Enthesitis Detected by Ultrasonography in Patients With Axial Spondyloarthritis—Anatomical Distribution, Morphology, and Response to Tumor Necrosis Factor-Inhibitor Therapy
por: Seven, Sengul, et al.
Publicado: (2020)

Etanercept in axial spondyloarthritis
por: Luo, Gui, et al.
Publicado: (2022)

Non-Radiographic Axial Spondyloarthritis (nr-axSpA): Advances in Classification, Imaging and Therapy
por: Robinson, Philip C., et al.
Publicado: (2019)

Impact of tumor necrosis factor α inhibitors on MRI inflammation in axial spondyloarthritis assessed by Spondyloarthritis Research Consortium Canada score: A meta-analysis
por: Huang, Yupeng, et al.
Publicado: (2020)

Feasibility, acceptability and change in health following a telephone-based cognitive behaviour therapy intervention for patients with axial spondyloarthritis
por: Pedley, Rebecca, et al.
Publicado: (2020)

Altered cytokine expression by macrophages from HLA-B27-positive spondyloarthritis patients without evidence of endoplasmic reticulum stress
por: Ambarus, Carmen A, et al.
Publicado: (2018)

Patient‐Reported Impact of Axial Spondyloarthritis on Working Life: Results From the European Map of Axial Spondyloarthritis Survey
por: Garrido‐Cumbrera, Marco, et al.
Publicado: (2021)

(Un)Spoken realities of living with axial spondyloarthritis: a qualitative study focused on couple experiences
por: Raybone, Kerry, et al.
Publicado: (2019)

Prevalence of axial spondyloarthritis in patients with acute anterior uveitis: a cross-sectional study utilising MRI
por: Sykes, Mark P, et al.
Publicado: (2018)

The Nonradiographic Axial Spondyloarthritis, the Radiographic Axial Spondyloarthritis, and Ankylosing Spondylitis: The Tangled Skein of Rheumatology
por: Malaviya, Anand N., et al.
Publicado: (2017)

A novel IMU-based clinical assessment protocol for Axial Spondyloarthritis: a protocol validation study
por: Franco, Luca, et al.
Publicado: (2021)

What is the optimal target for a T2T approach in axial spondyloarthritis?
por: Sieper, Joachim, et al.
Publicado: (2021)

Tumor necrosis factor inhibitor therapy but not standard therapy is associated with resolution of erosion in the sacroiliac joints of patients with axial spondyloarthritis
por: Pedersen, Susanne J, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_aiq93045vuvfrl7kp2t8lsi7sd